Free tool
FAERS Monitor: Prolia
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 125320 or its brand name (Prolia, Denosumab). Reports on generic versions are filed under their own applications.
Reports
203,628
Serious
111,298
55% of reports
Hospitalization
32,053
Death reported
26,093
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use36,806
- death20,597
- arthralgia8,975
- osteonecrosis of jaw8,703
- fatigue7,855
- pain in extremity7,063
- pain7,019
- back pain6,993
- nausea5,551
- diarrhoea5,433
- fall5,380
- rash4,374
- myalgia4,246
- asthenia4,134
- bone pain4,071
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 146 |
| 2011 | 1,755 |
| 2012 | 5,568 |
| 2013 | 7,360 |
| 2014 | 11,624 |
| 2015 | 12,375 |
| 2016 | 20,402 |
| 2017 | 33,839 |
| 2018 | 33,692 |
| 2019 | 11,455 |
| 2020 | 10,399 |
| 2021 | 10,073 |
| 2022 | 9,831 |
| 2023 | 10,693 |
| 2024 | 9,318 |
| 2025 | 7,953 |
| 2026 | 7,141 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,850,531 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| osteonecrosis of jawSignal | 8,703 | 55.5 | 54.1 | 302,225 |
| bone painSignal | 4,071 | 7.6 | 7.4 | 21,917 |
| off label useSignal | 36,806 | 4.5 | 4.4 | 99,739 |
| back painSignal | 6,993 | 3.2 | 3.1 | 10,214 |
| myalgiaSignal | 4,246 | 2.6 | 2.5 | 4,179 |
| pain in extremitySignal | 7,063 | 2.5 | 2.5 | 6,363 |
| deathSignal | 20,597 | 2.5 | 2.5 | 18,961 |
| arthralgiaSignal | 8,975 | 2.3 | 2.2 | 6,268 |
| fall | 5,380 | 1.7 | 1.6 | 1,482 |
| pain | 7,019 | 1.2 | 1.2 | 201 |
| asthenia | 4,134 | 1.1 | 1.1 | 69 |
| fatigue | 7,855 | 1.0 | 1.0 | 14 |
| rash | 4,374 | 1.0 | 1.0 | 6 |
| diarrhoea | 5,433 | 0.9 | 0.8 | 111 |
| nausea | 5,551 | 0.7 | 0.7 | 610 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.